Liquidia is a biopharmaceutical company focused on the development and commercialization of products that address unmet patient needs, with current focus directed towards the treatment of pulmonary arterial hypertension (PAH).
Kyverna Therapeutics
7 followers
Strand Therapeutics
3 followers
UNC Charlotte
13 followers
Calico
8 followers
Vera Therapeutics
6 followers
School District of Philadelphia
5 followers
Alpha
5 followers
DECA
4 followers
Mentor Collective
4 followers
Teaching Lab
3 followers
Mineralys Therapeutics
3 followers
iGEM
1 follower